It would make a lot of sense now that IMU is having CAR-T as one of its pipelines. CHM's Brain Cancer and NK-cell technologies are both close to start their registrational trials, that would mean in 2025 IMU could have 4 Rego trials. Imagine, if all 4 would be approved in 2026 / 2027.
CHM is atm valued worthless, but the GBM CAR-T is atm the most advanced GBM treatment - Imagine that! Then they are doing an NK-Cell AML trial in the US, approached by MD Anderson Texas due to fantastic ph 1 / 2 results. Again, CHM valued worthless.
Plus they got the green light to start the first ever direct attacking solid cancer CAR-T based on CD 17. That alone is more worth than $ ZERO.
And Hopper holds 19.99% of CHM. A t/o at 20c, about 200m EV, would make him a bit richer too. And me too, LOL.
GLTA
It would make a lot of sense now that IMU is having CAR-T as one...
-
- There are more pages in this discussion • 2,404 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.9¢ |
Change
0.001(1.04%) |
Mkt cap ! $360.7M | |||
| Open | High | Low | Value | Volume |
| 4.8¢ | 4.9¢ | 4.8¢ | $40.56K | 843.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 44 | 4744788 | 4.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.9¢ | 4179731 | 20 |
View Market Depth
| Last trade - 11.13am 11/10/2024 (20 minute delay) ? |
| IMU (ASX) Chart |